- Report
- May 2019
- 17 Pages
Global
From €598EUR$625USD£512GBP
€1195EUR$1,250USD£1,024GBP
- Report
- September 2019
Global
From €5135EUR$5,370USD£4,400GBP
Zenapax is a brand of immunosuppressive drug used to prevent organ rejection in transplant patients. It is a monoclonal antibody that binds to the interleukin-2 receptor, blocking the action of the cytokine interleukin-2. This prevents the body from attacking the transplanted organ, allowing it to survive and function normally. Zenapax is used in combination with other immunosuppressive drugs to reduce the risk of organ rejection.
Zenapax is manufactured by Hoffmann-La Roche, a Swiss pharmaceutical company. Other companies in the immunosuppressive drug market include Novartis, Astellas Pharma, and Bristol-Myers Squibb. These companies produce a variety of immunosuppressive drugs, including calcineurin inhibitors, mTOR inhibitors, and corticosteroids. Show Less Read more